The impact of risk factors on gastroparesis at an urban medical center.
Delayed gastric emptying
diabetes mellitus
narcotic medications
Journal
Annals of gastroenterology
ISSN: 1108-7471
Titre abrégé: Ann Gastroenterol
Pays: Greece
ID NLM: 101121847
Informations de publication
Date de publication:
Historique:
received:
28
08
2019
accepted:
29
01
2020
entrez:
9
5
2020
pubmed:
10
5
2020
medline:
10
5
2020
Statut:
ppublish
Résumé
Gastroparesis is a complex and poorly understood disease. The literature is lacking with respect to the epidemiology of patient comorbidities and their effect on gastric emptying. We aimed to describe the most common comorbid conditions among patients with gastroparesis in an urban population and quantify the effect of these comorbidities on the severity of delayed gastric emptying (DGE). We examined the medical records of all patients diagnosed with gastroparesis at a quaternary care center between 2014 and 2015. The severity of DGE was analyzed after patients were stratified for possible causative etiologies. Likelihood ratio tests were used to assess the significance of demographic and scintigraphic variation in this population. Of the 221 patients, 56.1% were Caucasian and 31.7% were African American. Among these patients, 29.4% had evidence of medication-associated gastroparesis, 29.0% had diabetes-associated gastroparesis, and 31.7% had idiopathic disease. African American patients with gastroparesis were more likely to have diabetic gastroparesis than patients of other races (P=0.01). There was a statistically significant relationship between the number of major risk factors and the severity of a patient's DGE (P=0.004). Among a diverse urban population, patients with DGE often carry multiple comorbid conditions that serve as risk factors for the development of gastroparesis, including prescriptions for narcotic medications. Greater numbers of these comorbid conditions are associated with more severe disease. Demographics are significantly associated with the etiology and severity of gastroparesis; in particular, African American patients are more likely to have diabetic gastroparesis than patients of other races.
Sections du résumé
BACKGROUND
BACKGROUND
Gastroparesis is a complex and poorly understood disease. The literature is lacking with respect to the epidemiology of patient comorbidities and their effect on gastric emptying. We aimed to describe the most common comorbid conditions among patients with gastroparesis in an urban population and quantify the effect of these comorbidities on the severity of delayed gastric emptying (DGE).
METHODS
METHODS
We examined the medical records of all patients diagnosed with gastroparesis at a quaternary care center between 2014 and 2015. The severity of DGE was analyzed after patients were stratified for possible causative etiologies. Likelihood ratio tests were used to assess the significance of demographic and scintigraphic variation in this population.
RESULTS
RESULTS
Of the 221 patients, 56.1% were Caucasian and 31.7% were African American. Among these patients, 29.4% had evidence of medication-associated gastroparesis, 29.0% had diabetes-associated gastroparesis, and 31.7% had idiopathic disease. African American patients with gastroparesis were more likely to have diabetic gastroparesis than patients of other races (P=0.01). There was a statistically significant relationship between the number of major risk factors and the severity of a patient's DGE (P=0.004).
CONCLUSIONS
CONCLUSIONS
Among a diverse urban population, patients with DGE often carry multiple comorbid conditions that serve as risk factors for the development of gastroparesis, including prescriptions for narcotic medications. Greater numbers of these comorbid conditions are associated with more severe disease. Demographics are significantly associated with the etiology and severity of gastroparesis; in particular, African American patients are more likely to have diabetic gastroparesis than patients of other races.
Identifiants
pubmed: 32382227
doi: 10.20524/aog.2020.0475
pii: AnnGastroenterol-33-250
pmc: PMC7196617
doi:
Types de publication
Journal Article
Langues
eng
Pagination
250-256Informations de copyright
Copyright: © Hellenic Society of Gastroenterology.
Déclaration de conflit d'intérêts
Conflict of Interest: None
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Gastroenterol. 2013 Jan;108(1):18-37; quiz 38
pubmed: 23147521
Gastroenterol Clin North Am. 2015 Mar;44(1):59-68
pubmed: 25667023
J Clin Gastroenterol. 1989 Dec;11(6):625-30
pubmed: 2584662
Dig Dis Sci. 1998 Nov;43(11):2398-404
pubmed: 9824125
Dig Dis Sci. 1998 Sep;43(9):1951-6
pubmed: 9753257
Gastroenterology. 2011 Jan;140(1):101-15
pubmed: 20965184
J Clin Endocrinol Metab. 2009 Jun;94(6):1853-78
pubmed: 19494161
Clin Gastroenterol Hepatol. 2011 Dec;9(12):1056-64; quiz e133-4
pubmed: 21871247
J Clin Pharmacol. 1998 Nov;38(11):1017-20
pubmed: 9824782
Am J Gastroenterol. 2001 Jan;96(1):77-83
pubmed: 11197291
J Clin Gastroenterol. 1990 Oct;12(5):505-12
pubmed: 2229993
Dig Dis Sci. 2014 Nov;59(11):2656-65
pubmed: 25258035
JAMA. 2013 Dec 25;310(24):2640-9
pubmed: 24368464
Am J Surg. 1996 Jul;172(1):24-8
pubmed: 8686797
Gut. 2003 Jul;52(7):966-70
pubmed: 12801952
Clin Gastroenterol Hepatol. 2011 Jan;9(1):5-12; quiz e7
pubmed: 20951838
Am J Public Health. 2014 Nov;104(11):2147-55
pubmed: 24228660
Dig Dis Sci. 2002 Dec;47(12):2664-8
pubmed: 12498282
Am J Gastroenterol. 1989 Sep;84(9):1069-75
pubmed: 2773901
Diabetologia. 1989 Mar;32(3):151-9
pubmed: 2753246
Parkinsonism Relat Disord. 2011 Jan;17(1):10-5
pubmed: 20829091
J Rheumatol. 2010 Nov;37(11):2313-8
pubmed: 20810502
Br J Clin Pharmacol. 1975 Dec;2(6):509-13
pubmed: 9953
Aliment Pharmacol Ther. 2017 Apr;45(7):883-898
pubmed: 28185291
Gut. 1980 Sep;21(9):753-9
pubmed: 7429340
Can J Gastroenterol. 2005 Mar;19(3):141-5
pubmed: 15776133
Clin Gastroenterol Hepatol. 2008 Sep;6(9):988-92
pubmed: 18599359
J Pediatr. 1997 Nov;131(5):751-4
pubmed: 9403659
Gastroenterology. 2011 May;140(5):1575-85.e8
pubmed: 21300066
Scand J Gastroenterol. 1993 May;28(5):427-32
pubmed: 8511503
Gastroenterol Res Pract. 2009;2009:529802
pubmed: 20224642
Aliment Pharmacol Ther. 2008 May;27(9):724-40
pubmed: 18248660
Br J Pharmacol. 1986 Dec;89(4):627-33
pubmed: 3814903
Neurogastroenterol Motil. 2012 Jul;24(7):597-603
pubmed: 22626059
Am J Gastroenterol. 1987 Jan;82(1):29-35
pubmed: 3799578
Gastroenterology. 2009 Apr;136(4):1225-33
pubmed: 19249393
Gastroenterology. 2004 Nov;127(5):1592-622
pubmed: 15521026
J Clin Gastroenterol. 2013 Oct;47(9):757-61
pubmed: 23426455
Am J Gastroenterol. 2012 Jan;107(1):82-8
pubmed: 22085818
J Neurol. 2006 Feb;253 Suppl 1:I3-9
pubmed: 16477484
Am J Gastroenterol. 1997 Sep;92(9):1501-4
pubmed: 9317072
Am J Gastroenterol. 2008 Mar;103(3):753-63
pubmed: 18028513
Clin Gastroenterol Hepatol. 2019 Jul;17(8):1489-1499.e8
pubmed: 30404035
Eur J Gastroenterol Hepatol. 1997 Sep;9(9):901-4
pubmed: 9355790
Neurogastroenterol Motil. 2015 Nov;27(11):1657-66
pubmed: 26376608
N Engl J Med. 2007 Feb 22;356(8):820-9
pubmed: 17314341
J Clin Gastroenterol. 2010 Jul;44(6):402-6
pubmed: 20351569
Diabetes Care. 2001 Jul;24(7):1264-9
pubmed: 11423513
Obes Surg. 2006 Sep;16(9):1243-5
pubmed: 16989712
Nat Clin Pract Gastroenterol Hepatol. 2007 Jun;4(6):336-46
pubmed: 17541447
Diabetes Care. 1999 Mar;22(3):503-7
pubmed: 10097936
J Gastroenterol Hepatol. 2007 Sep;22(9):1423-8
pubmed: 17716347
Gastroenterology. 1989 Jan;96(1):110-5
pubmed: 2909417
Gastroenterology. 2015 Aug;149(2):340-9.e2
pubmed: 25921377